Andrew Catanzaro

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

The Journal of Infectious Diseases · 2006 · First of 20 authors · 264 citations

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro

Journal of Clinical Investigation · 1998 · 233 citations